Protamine and Heparin Interactions: A Narrative Review

被引:2
作者
Crivellari, Martina [1 ]
Landoni, Giovanni [1 ,2 ]
Ursoleo, Jacopo D'Andria [1 ]
Ferrante, Luca [2 ]
Oriani, Alessandro [1 ]
机构
[1] IRCCS San Raffaele Sci Inst, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Via Olgettina 58, I-20132 Milan, Italy
关键词
Activated clotting time; bleeding; cardiac anesthesia; cardiopulmonary bypass; coagulation; heparin; protamine; ACTIVATED CLOTTING TIME; EXTRACORPOREAL MEMBRANE-OXYGENATION; CARDIAC-SURGERY; COAGULATION; SULFATE; ANTICOAGULATION; ARTERIAL; REVERSAL; IMPACT; BYPASS;
D O I
10.4103/aca.aca_117_23
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Protamine, first isolated from salmon fish sperm and now produced through recombinant biotechnology, is an antidote that neutralizes the anticoagulant properties of heparin. Protamine function is based on the capacity to dissociate the heparin-antithrombin III (AT III) complex (an important link that promotes blood fluidification by inhibiting coagulation), forming the inactive heparin-protamine complex. Protamine has itself dose-dependent anticoagulant properties: It interferes with coagulation factors and platelet function; it stimulates fibrinolysis; it can lead to thrombocytopenia and reduction in thrombin-related platelet aggregation; it decreases platelet response to thrombin receptor agonist in a dose-dependent manner. In this review, we will focus on protamine and its interaction with heparin. Notably, protamine is able to antagonize not only unfractionated heparin (UFH) but also low molecular weight heparins to various degrees. Protamine-allergic and anaphylactoid systemic reactions may affect up to 1 in 10 people and should be prevented and treated early.
引用
收藏
页码:202 / 212
页数:11
相关论文
共 62 条
  • [1] Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation
    Ainle, Fionnuala Ni
    Preston, Roger J. S.
    Jenkins, P. Vincent
    Nel, Hendrik J.
    Johnson, Jennifer A.
    Smith, Owen P.
    White, Barry
    Fallon, Padraic G.
    O'Donnell, James S.
    [J]. BLOOD, 2009, 114 (08) : 1658 - 1665
  • [2] The effects of heparinase 1 and protamine on platelet reactivity
    Ammar, T
    Fisher, CF
    [J]. ANESTHESIOLOGY, 1997, 86 (06) : 1382 - 1386
  • [3] Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants
    Ansell, Jack
    Laulicht, Bryan E.
    Bakhru, Sasha H.
    Burnett, Allison
    Jiang, Xuan
    Chen, Lirong
    Baker, Christopher
    Villano, Stephen
    Steiner, Solomon
    [J]. BLOOD, 2021, 137 (01) : 115 - 125
  • [4] Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients
    Atallah, S.
    Liebl, M.
    Fitousis, K.
    Bostan, F.
    Masud, F.
    [J]. PERFUSION-UK, 2014, 29 (05): : 456 - 461
  • [5] The protamine family of sperm nuclear proteins
    Balhorn, Rod
    [J]. GENOME BIOLOGY, 2007, 8 (09):
  • [6] Barstad RM, 2000, THROMB HAEMOSTASIS, V83, P334
  • [7] Advances in the preparation and synthesis of heparin and related products
    Baytas, Sultan N.
    Linhardt, Robert J.
    [J]. DRUG DISCOVERY TODAY, 2020, 25 (12) : 2095 - 2109
  • [8] An introduction to point-of-care testing in extracorporeal circulation and LVADs
    Bercovitz, Rachel Sara
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 516 - 521
  • [9] Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review
    Boer, C.
    Meesters, M. I.
    Veerhoek, D.
    Vonk, A. B. A.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (05) : 914 - 927
  • [10] AT HIGH HEPARIN CONCENTRATIONS, PROTAMINE CONCENTRATIONS WHICH REVERSE HEPARIN ANTICOAGULANT EFFECTS ARE INSUFFICIENT TO REVERSE HEPARIN ANTIPLATETLET EFFECTS
    CARR, ME
    CARR, SL
    [J]. THROMBOSIS RESEARCH, 1994, 75 (06) : 617 - 630